<DOC>
	<DOCNO>NCT02096679</DOCNO>
	<brief_summary>Study evaluate pharmacokinetic Mass Balance single dose [ 14C ] AZD9291 healthy male volunteer</brief_summary>
	<brief_title>Study Evaluating Pharmacokinetic Mass Balance Single Dose 14C AZD9291 Volunteers</brief_title>
	<detailed_description>A Single-centre , Non-Randomised , Open-label , Pharmacokinetic Mass Balance Study Orally Administered [ 14C ] -AZD9291 Healthy Male Volunteers</detailed_description>
	<mesh_term>Osimertinib</mesh_term>
	<criteria>1 , Volunteers must willing use reliable method contraception ( condom spermicide ) , even partner postmenopausal , surgically sterile , use effective hormonal method contraception intrauterine coil . 2 . In addition , volunteer must agree continue take similar contraceptive precaution 6 month last administration AZD9291 avoid procreative sex well sperm donation 6 month . 1 , Any clinically relevant abnormality physical examination , vital sign , hematology , clinical chemistry , urinalysis ECG baseline opinion investigator . 2 . Radiation exposure clinical study , include present study , exclude background radiation include diagnostic Xrays medical exposure , exceed 5 mSv last 12 month 10 mSv last 5 year .</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Phase I , healthy , pharmacokinetics , Mass balance</keyword>
</DOC>